Chief Scientific Officer - Immuno-Oncology & TCE Strategy

Shennon Biotechnologies

San Francisco (CA)

On-site

USD 350,000 - 450,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Shennon Bio seeks an accomplished CSO to lead R&D and drive translational immunology programs from discovery through clinical development. The role collaborates with the CEO and advisors to shape the pipeline, form strategic partnerships, and advance TCE programs with an entrepreneurial, data-driven approach.

The CSO will build and scale the R&D organization, maintain relationships with pharma and clinical collaborators, and present compelling data to the board in support of growth initiatives

Qualifications

  • Ph.D. in immuno-oncology with 10+ years of industry experience in design, management and leadership of R&D programs.
  • Domain expertise in immuno-oncology and TCEs.
  • Deep expertise in directing TCE programs into the clinic.
  • Proven ability to direct pre-clinical assets to IND and clinical trials.
  • Pre-established relationships with pharma companies and partners.
  • Experience scaling a pre-clinical company to commercial success with capital efficiency.
  • Entrepreneurial mindset and ability to present to executives and the board.

Responsibilities

  • Collaborate with the CEO and advisors to scale and refine the pipeline for external partnerships and in-house programs.
  • Lead the R&D team to refine the pipeline and drive lead candidates forward.
  • Establish a strategic roadmap and present data-driven insights to the CEO and board.
  • Lead efforts to scale the organization in terms of scientific talent and capital equipment.
  • Establish and maintain relationships with external collaborators such as clinicians, biotech and pharma leaders.
  • Organize strategic communications with internal and external partners aligned with growth strategy.

Skills

Immuno-oncology
TCEs
Leadership
Strategic roadmap
Data-driven
Stakeholder management

Education

Ph.D. in immuno-oncology

Job description

Shennon Bio seeks an accomplished CSO to lead R&D and drive translational immunology programs from discovery through clinical development. The role collaborates with the CEO and advisors to shape the pipeline, form strategic partnerships, and advance TCE programs with an entrepreneurial, data-driven approach.

The CSO will build and scale the R&D organization, maintain relationships with pharma and clinical collaborators, and present compelling data to the board in support of growth initiatives

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

CSO / VP of R&D
CSO / VP of R&D

Shennon Biotechnologies • San Francisco (CA)

On-site
USD 350,000 - 450,000
Chief Scientific Officer, Cell Therapy & Immunotherapy
Chief Scientific Officer, Cell Therapy & Immunotherapy

Legend Biotech, Inc. • New Jersey

On-site
USD 435,000 - 571,000
Medical, dental, and vision insurance
401(k) with company match
Paid parental leave
Senior TCE Development Scientist | Biologics & Immunology
Senior TCE Development Scientist | Biologics & Immunology

Shennon Biotechnologies • San Francisco (CA)

On-site
USD 120,000 - 160,000
Daily lunches
Commuter benefits
Snacks & drinks
+3
Chief Immunology & Biologics Officer
Chief Immunology & Biologics Officer

Enigma Search • Redwood City (CA)

On-site
USD 300,000 - 600,000
CMC Asset Lead (Fully Remote)
CMC Asset Lead (Fully Remote)

Shennon Biotechnologies • United States

Remote
USD 250,000 - 380,000
CSO, Neurology Biotech: Lead First-in-Class Antibody
CSO, Neurology Biotech: Lead First-in-Class Antibody

Nexia • United States

Remote
USD 300,000 - 520,000
Equity participation
CMC Asset Lead - Immunotherapy, IND Enablement
CMC Asset Lead - Immunotherapy, IND Enablement

Shennon Biotechnologies • United States

Remote
USD 250,000 - 380,000
Director, CMC Lead — Multispecific Antibodies (Remote)
Director, CMC Lead — Multispecific Antibodies (Remote)

Shennon Biotechnologies • San Francisco (CA)

On-site
USD 260,000 - 420,000
Chief Scientist, Cancer Genomics & Strategy
Chief Scientist, Cancer Genomics & Strategy

TESA Research, Inc. • Park City (UT)

Hybrid
USD 180,000 - 300,000
Equity ownership
Competitive base salary
Autonomy in work planning
+2
Senior Director, Oncology Clinical Science Strategy
Senior Director, Oncology Clinical Science Strategy

CytomX Therapeutics, Inc. • Emeryville (CA)

Hybrid
USD 260,000 - 330,000